RE: Director share buying4 Feb 2025 14:20
Hi Popeye, I've just had a quick look at this, there is a limited amount of shares in issue 62.06m, directors have some skin in the game which is a good sign, but would be good to see more uptake by them. I note the acquisition at E80,000 relating to Abiss, my only question there is, has that really come along a bit too early? or was it a bargain to behold? time will tell, but if it turns out to be a bad move, it could sink the business possibly? I haven't got very far as yet with research, but can someone shed some light for me please, what happened with the new contract partner (see rns 24 July 2024)? have they converted to a longer term supply contract? That information is crucial imo. If not, why have they been lost?
Medical implantables is big business. Whilst I've no first hand experience or knowledge of female stress urinary incontinence thank heavens! I have been advised recently to have a loop recorder implant relating to atrial fibrillation and it comes at a hefty price of around 9k including monitoring. So implantables together with associated product lines are big business, and so I will definitely research some more.